company
PAI Holdings LLC
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · drug_recall2026-06-24PAI Holdings LLC — Class II recall: VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 25 Grams Act…
- fda_recall · drug_recall2026-06-24PAI Holdings LLC — Class II recall: VistaPharm, KERR INSTA-CHAR IN AN SORBITOL BASE WITH CHERRY FLAVOR, 50 Grams Act…
- fda_recall · drug_recall2026-06-24PAI Holdings LLC — Class II recall: VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 50 Grams Acti…
- fda_recall · drug_recall2026-06-24PAI Holdings LLC — Class II recall: VistaPharm, KERR INSTA-CHAR IN AN AQUEOUS BASE WITH CHERRY FLAVOR, 25 Grams Acti…
Frequently asked questions
- How many FDA warning letters has PAI Holdings LLC received?
- Argus HQ has not recorded an FDA warning letter for PAI Holdings LLC in our current dataset.
- What FDA recalls has PAI Holdings LLC issued?
- Argus HQ has recorded 4 FDA recalls tied to PAI Holdings LLC.
- Is PAI Holdings LLC FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 4 recalls, and 0 approval records for PAI Holdings LLC. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.